The immune regulation in cancer by the amino acid metabolizing enzymes ARG and IDO
- 1 August 2017
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 35, 30-39
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Acute myeloid leukemia creates an arginase-dependent immunosuppressive microenvironmentBlood, 2013
- Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic CancerPLOS ONE, 2013
- Chemokine nitration prevents intratumoral infiltration of antigen-specific T cellsJournal of Experimental Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Androgen-Regulated Expression of Arginase 1, Arginase 2 and Interleukin-8 in Human Prostate CancerPLOS ONE, 2010
- Understanding the Warburg Effect: The Metabolic Requirements of Cell ProliferationScience, 2009
- SOCS3 drives proteasomal degradation of indoleamine 2,3-dioxygenase (IDO) and antagonizes IDO-dependent tolerogenesisProceedings of the National Academy of Sciences, 2008
- Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell functionJournal of Experimental Medicine, 2006
- l-arginine availability regulates T-lymphocyte cell-cycle progressionBlood, 2006
- Regulation of immune responses by L-arginine metabolismNature Reviews Immunology, 2005